Investor Hub

Novavax is a global biotechnology company focused on developing our R&D assets and establishing partnerships to maximize the impact of our cutting-edge technology in protecting health.

Latest quarterly earnings
Latest investor presentation
Latest clinical presentation
Annual report
Latest publications
NASDAQ:NVAX
Loading data...
NASDAQ:NVAX
Loading data...
Latest quarterly earnings
Latest investor presentation
Latest clinical presentation
Annual report
Latest publications

Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings and more.

Shareholders seeking information can contact investor relations at (240) 268-2022 or contact us.

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.